**Abstract**

Neoadjuvant chemotherapy has been increasingly recommended to women with large or locally advanced breast cancer to improve surgical outcomes and to raise the opportunities for breast-conserving therapy. While the women with breast cancer are treated with neoadjuvant chemotherapy, they could have several distress symptoms diminishing their quality of life (QOL) and positive psychosocial factors maintaining their QOL. This study explored the QOL and related factors in women with breast cancer undergoing initial neoadjuvant chemotherapy.

The participants were 114 women with stage II or III breast cancer treated with their neoadjuvant chemotherapy. Initial evaluation was conducted before first neoadjuvant chemotherapy and second evaluation was conducted before second neoadjuvant chemotherapy. Self-report instruments used to assess QOL and related factors included the Functional Assessment of Cancer Therapy-Breast (FACT-B), the Pittsburgh Sleep Quality Index (PSQI), the Hospital Anxiety and Depression Scale (HADS), the Fatigue Severity Scale (FSS), the M.D. Anderson Symptom Inventory, the Multidimensional Scale of Perceived Social Support, the Adult Dispositional Hope Scale, and the Perceived stress scale.

Between before and after initial neoadjuvant chemotherapy, there is no significant difference in FACT-B total scores. But in the FACT-B subscales, emotional well-being domain (P\<0.001) was significantly lower after initial chemotherapy. HADS (P\<0.001) and FSS (P=0.001) score were higher after initial chemotherapy. Whereas PSQI score was no significant difference between before and after initial chemotherapy. In a multivariate analysis, most powerful predictor of QOL after initial chemotherapy was anxiety. Altogether perceived stress, social support and fatigue were also related to the variance of QOL in the participants.

These result suggest that women with breast cancer undergoing neoadjuvant chemotherapy are at higher risk for diminished QOL, especially in emotional domain. Those at high risk for lower QOL, may need interventions that specifically target related anxiety, stress, social support and fatigue.
